STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Natera, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Natera, Inc. (NTRA) filing of Form 144 notifies the SEC of a proposed sale of 2,750 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $459,222.50. The shares represent part of a restricted stock grant acquired from the issuer on 06/09/2024.

The filing lists an approximate sale date of 08/28/2025 and reports 137,248,106 shares outstanding. The filer states there were no securities sold in the past three months and makes the standard representation that they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine notice of proposed insider sale; small lot relative to shares outstanding, appears informational rather than material.

The Form 144 documents a proposed sale of 2,750 restricted shares acquired 06/09/2024, mediated by Morgan Stanley Smith Barney, with an indicated aggregate value of $459,222.50 and target sale date 08/28/2025. Against 137,248,106 shares outstanding, the size is immaterial to market capitalization and unlikely to affect share supply materially. The filing complies with Rule 144 disclosure requirements and includes the standard attestation regarding material nonpublic information.

TL;DR: Compliance-focused filing showing disclosure of an insider sale under Rule 144; no governance red flags present in the notice.

The notice indicates the securities were restricted stock from the issuer and were acquired 06/09/2024, with no prior sales in the past three months reported. The use of an established broker and the attestation about material information suggest procedural adherence to securities rules. The document contains no indication of unusual terms, related-party transfers, or aggregated sales that would typically raise governance concerns.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

32.73B
133.33M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN